Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries Medical Dialogues Bureau11 April 2020 9:30 AM ISTParis: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could...
Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT Medical Dialogues Bureau9 April 2020 10:00 AM ISTNew York: President Donald Trump, who has aggressively promoted the use of hydroxychloroquine to treat coronavirus patients in and has asked India to...
Sanofi delays Slump Sale and transfer of Ankleshwar plant Medical Dialogues Bureau30 March 2020 3:30 PM ISTGujrat: Sanofi has announced the change in date for the closing of a transaction relating to Slump Sale and transfer of its manufacturing facility of...
Ibuprofen and Covid-19: Drugmaker Sanofi defends Molecule, WHO updates its stand Medical Dialogues Bureau21 March 2020 1:35 PM ISTNew Delhi: Responding to the World Health Organisation statement earlier that recommended avoidance of Ibuprofen due to its suspected worserning...
Regeneron, Sanofi begin testing use of Arthritis Drug Kevzara to treat COVID-19 Medical Dialogues Bureau18 March 2020 12:24 PM ISTKevzara is a fully-human monoclonal antibody that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor.The use of...
Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi Medical Dialogues Bureau12 March 2020 11:29 AM ISTInsulin Glargine is a long-acting insulin used to treat adults with Type 2 diabetes and adults and paediatric patients with Type 1 diabetes for the...
Sanofi gets USFDA nod for Sarclisa (isatuximab-irfc) for refractory multiple myeloma Medical Dialogues Bureau4 March 2020 12:11 PM ISTSarclisa offers an intravenous (IV) administration and is dosed at 10 mg/kg, in combination with pom-dex, every week for four weeks and then every two...
Sanofi to pay USD 11.9 million to resolve US drug charity kickback probe Medical Dialogues Bureau2 March 2020 12:05 PM ISTSanofi SA has agreed to pay $11.85 million to resolve U.S. allegations that it used a charity that helps cover Medicare patients' out-of-pocket drug...
Sanofi plans to create standalone company dedicated to making APIs Medical Dialogues Bureau26 Feb 2020 3:37 PM ISTPARIS : Sanofi plans to create a standalone company dedicated to making active pharmaceutical ingredients (API), components that are biologically...
Top Cos in pharmaceutical supply chain develop Blockchain system to track prescription drugs, stop counterfeit Medical Dialogues Bureau22 Feb 2020 4:04 PM ISTAmong the 24 participating companies are Amgen Inc, FedEx Corp, GlaxoSmithKline Plc, Novartis, AmerisourceBergen Corp , Sanofi ), Walgreens Boots...
Sanofi joins forces with US Department of Health to advance a novel coronavirus vaccine MD bureau19 Feb 2020 3:03 PM ISTIndia: Sanofi Pasteur, the vaccines global business unit of Sanofi, will leverage previous development work for a SARS vaccine which may unlock a fast...
Marketing right for SGLT2 inhibitor Apleway to be transferred from Sanofi to Kowa Medical Dialogues Bureau18 Feb 2020 12:53 PM ISTChugai and Sanofi agreed to terminate their license agreement. Kowa and Sanofi agreed that the marketing right for Apleway will be transferred from...
